Transforming growth factor-β negatively modulates proliferation and c- fos expression of the human endometrial adenocarcinoma cell line HEC-1-A

Gynecologic Oncology

Volumn 65, Issue 1, 1997, Pages 63-68

  Bergman, Cynthia A ^a,b   Talavera, Francisco ^a   Christman, Gregory M ^a   Baker, Vicki V ^a   Roberts, James A ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; DOSE TIME EFFECT RELATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE;

EID: 0031127150     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4614     Document Type: Article

References (25)

1. 1. Roberts A, Sporn M: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1-9, 1993
2. INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261, 1994
3. 3. Stoscheck CM, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030-1037, 1986
4. 4. Ransone LJ, Verma IM: Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6:539-557, 1990
5. 5. Coffey RJ Jr, Bascom CC, Sipes NJ, Graves-Deal R, Weissman B, Moses HL: Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol 8:3088-3093, 1988
6. 6. Pietenpol JA, Holt JT, Stein RW, Moses HL: Transforming growth factor β1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87:3758-3762, 1990
7. 7. Pearl ML, Talavera F, Gretz H, Roberts JA, Menon KMJ: Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE. Gynecol Oncol 49:325-332, 1993
8. 8. Kang J, Talavera F, Connor P, Roberts JA, Menon KMJ: Effect of epidermal growth factor in c-fos mRNA proto-oncogene expression in human endometrial adenocarcinoma cell line HEC-1-A. Soc Gynecol Invest 41:252A
9. 9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
10. 10. Feinberg AP, Vogelstein B: A technique for radiolabeling cDNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
11. 11. Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L: DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 76:1373-1376, 1979
12. 12. German CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051, 1982
13. 13. Boyd JA, Kaufman DG: Expression of transforming growth factor β1 by human endometrial carcinoma cell lines: Inverse correlation with effects on growth rate and morphology. Cancer Res 50:3394-3399, 1990
14. 14. Talavera F, Bergman C, Pearl ML, Connor P, Roberts JA, Menon KMJ: cAMP and PMA potentiate the effects of IGF-I in the proliferation of endometrial adenocarcinoma cell line HEC-1-A by acting at the G1 phase of the cell cycle. Cell Prolif 28:121-136, 1995
15. 15. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG: Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1. Exp Cell Res 181:442-453, 1989
16. 16. Wollenberg GK, Semple E, Quinn BA, Hayes MA: Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta. Cancer Res 47:6595-6599, 1987
17. 17. Ranganathan G, Getz MJ: Cooperative stimulation of specific gene transcription by epidermal growth factor and transforming growth factor type β1. J Biol Chem 265:3001-3004, 1990
18. 18. Kovary K, Bravo R: The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 11:4466-4472, 1991
19. 19. Pai SR, Bird RC: c-fos expression is required during all phases of the cell cycle during exponential cell proliferation. Anticancer Res 14:985-994, 1994
20. 20. Shyu A-B, Greenberg ME, Belasco JG: The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev 3:60-72, 1989
21. 21. Fisch TE, Prywes R, Roeder RG: c-fos sequences necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbal-13-acetate, and the calcium ionophore. Mol Cell Biol 7:3490-3502, 1987
22. 22. Fisch TE, Prywes R, Roeder RG: An AP-1 binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbal-13-acetate. Mol Cell Biol 9:1327-1331, 1989
23. 23. Reddy K, Howe P: Transforming growth factor-β1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol 156:48-55, 1993
24. 24. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen R-M, Blenis J, Greenberg ME: A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mo1 Cell Biol 13:6260-6273, 1993
25. 25. Howe PH, Dobrowolski SF, Reddy KB, Stacey DW: Release from G1 growth arrest by transforming growth factor β1 requires cellular ras activity. J Biol Chem 268:21448-21452, 1993